Jilin Province Huinan Changlong Bio-pharmacy Company Limited (8049.HK)
HKD 1.39
(-0.71%)
HKD 1.39
(-0.71%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 841.54 Million CNY | -0.0% |
| 2022 | 841.58 Million CNY | 19.3% |
| 2021 | 705.45 Million CNY | 13.37% |
| 2020 | 622.25 Million CNY | -3.66% |
| 2019 | 645.88 Million CNY | -0.28% |
| 2018 | 647.67 Million CNY | 0.37% |
| 2017 | 645.3 Million CNY | -1.35% |
| 2016 | 654.11 Million CNY | 21.33% |
| 2015 | 539.13 Million CNY | -10.4% |
| 2014 | 601.71 Million CNY | 31.45% |
| 2013 | 457.74 Million CNY | 29.58% |
| 2012 | 353.24 Million CNY | 28.78% |
| 2011 | 274.29 Million CNY | 36.72% |
| 2010 | 200.63 Million CNY | 31.33% |
| 2009 | 152.76 Million CNY | 20.17% |
| 2008 | 127.12 Million CNY | 30.67% |
| 2007 | 97.28 Million CNY | 39.93% |
| 2006 | 69.52 Million CNY | -15.1% |
| 2005 | 81.88 Million CNY | -2.5% |
| 2004 | 83.98 Million CNY | -8.3% |
| 2003 | 91.59 Million CNY | 13.45% |
| 2002 | 80.73 Million CNY | -19.37% |
| 2001 | 100.12 Million CNY | 0.51% |
| 2000 | 99.61 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 196.54 Million CNY | 0.0% |
| 2024 Q1 | 196.54 Million CNY | -20.97% |
| 2023 Q3 | 197.2 Million CNY | -22.08% |
| 2023 Q1 | 142.54 Million CNY | -42.56% |
| 2023 Q2 | 253.09 Million CNY | 77.55% |
| 2023 FY | 841.54 Million CNY | -0.0% |
| 2023 Q4 | 248.7 Million CNY | 26.12% |
| 2022 FY | 841.58 Million CNY | 19.3% |
| 2022 Q3 | 216.12 Million CNY | 17.5% |
| 2022 Q4 | 248.17 Million CNY | 14.83% |
| 2022 Q1 | 193.36 Million CNY | -16.58% |
| 2022 Q2 | 183.92 Million CNY | -4.88% |
| 2021 Q1 | 148.71 Million CNY | -18.19% |
| 2021 Q3 | 172.33 Million CNY | 12.93% |
| 2021 FY | 705.45 Million CNY | 13.37% |
| 2021 Q4 | 231.79 Million CNY | 34.5% |
| 2021 Q2 | 152.6 Million CNY | 2.61% |
| 2020 Q1 | 129.95 Million CNY | -25.24% |
| 2020 Q2 | 155.69 Million CNY | 19.81% |
| 2020 Q3 | 154.82 Million CNY | -0.56% |
| 2020 Q4 | 181.77 Million CNY | 17.41% |
| 2020 FY | 622.25 Million CNY | -3.66% |
| 2019 FY | 645.88 Million CNY | -0.28% |
| 2019 Q4 | 173.82 Million CNY | 0.68% |
| 2019 Q3 | 172.65 Million CNY | 8.97% |
| 2019 Q1 | 140.96 Million CNY | -14.4% |
| 2019 Q2 | 158.44 Million CNY | 12.4% |
| 2018 FY | 647.67 Million CNY | 0.37% |
| 2018 Q3 | 170.92 Million CNY | 12.77% |
| 2018 Q4 | 164.68 Million CNY | -3.65% |
| 2018 Q2 | 151.56 Million CNY | -5.57% |
| 2018 Q1 | 160.5 Million CNY | -1.72% |
| 2017 Q2 | 156.42 Million CNY | 2.19% |
| 2017 Q3 | 172.48 Million CNY | 10.27% |
| 2017 FY | 645.3 Million CNY | -1.35% |
| 2017 Q4 | 163.32 Million CNY | -5.31% |
| 2017 Q1 | 153.06 Million CNY | -15.25% |
| 2016 FY | 654.11 Million CNY | 21.33% |
| 2016 Q4 | 180.6 Million CNY | 2.31% |
| 2016 Q3 | 176.52 Million CNY | 19.78% |
| 2016 Q2 | 147.37 Million CNY | -1.5% |
| 2016 Q1 | 149.61 Million CNY | 6.73% |
| 2015 FY | 539.13 Million CNY | -10.4% |
| 2015 Q1 | 121.73 Million CNY | -45.63% |
| 2015 Q2 | 142.54 Million CNY | 17.1% |
| 2015 Q3 | 134.66 Million CNY | -5.53% |
| 2015 Q4 | 140.18 Million CNY | 4.1% |
| 2014 Q2 | 134.57 Million CNY | 24.92% |
| 2014 FY | 601.71 Million CNY | 31.45% |
| 2014 Q4 | 223.9 Million CNY | 65.23% |
| 2014 Q3 | 135.51 Million CNY | 0.7% |
| 2014 Q1 | 107.72 Million CNY | -23.32% |
| 2013 Q3 | 103.98 Million CNY | -8.99% |
| 2013 FY | 457.74 Million CNY | 29.58% |
| 2013 Q1 | 99 Million CNY | -13.7% |
| 2013 Q2 | 114.25 Million CNY | 15.4% |
| 2013 Q4 | 140.49 Million CNY | 35.12% |
| 2012 Q4 | 114.72 Million CNY | 17.15% |
| 2012 Q2 | 140.59 Million CNY | 106.65% |
| 2012 FY | 353.24 Million CNY | 28.78% |
| 2012 Q1 | 68.03 Million CNY | -32.8% |
| 2012 Q3 | 97.92 Million CNY | -30.35% |
| 2011 Q1 | 45.12 Million CNY | -25.54% |
| 2011 Q2 | 59.12 Million CNY | 31.04% |
| 2011 Q3 | 68.8 Million CNY | 16.37% |
| 2011 Q4 | 101.23 Million CNY | 47.13% |
| 2011 FY | 274.29 Million CNY | 36.72% |
| 2010 Q1 | 35.45 Million CNY | 0.0% |
| 2010 FY | 200.63 Million CNY | 31.33% |
| 2010 Q3 | 40.61 Million CNY | -36.51% |
| 2010 Q4 | 60.59 Million CNY | 49.21% |
| 2010 Q2 | 63.96 Million CNY | 80.43% |
| 2009 FY | 152.76 Million CNY | 20.17% |
| 2009 Q2 | 34.14 Million CNY | 0.0% |
| 2008 FY | 127.12 Million CNY | 30.67% |
| 2007 FY | 97.28 Million CNY | 39.93% |
| 2006 FY | 69.52 Million CNY | -15.1% |
| 2005 FY | 81.88 Million CNY | -2.5% |
| 2004 FY | 83.98 Million CNY | -8.3% |
| 2003 FY | 91.59 Million CNY | 13.45% |
| 2002 FY | 80.73 Million CNY | -19.37% |
| 2001 FY | 100.12 Million CNY | 0.51% |
| 2000 FY | 99.61 Million CNY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 259.15 Million HKD | -224.723% |
| Grand Pharmaceutical Group Limited | 10.52 Billion HKD | 92.008% |
| Extrawell Pharmaceutical Holdings Limited | 59.09 Million HKD | -1323.982% |
| Wai Yuen Tong Medicine Holdings Limited | 783.88 Million HKD | -7.356% |
| Qianhai Health Holdings Limited | 961.29 Million HKD | 12.457% |
| Lee's Pharmaceutical Holdings Limited | 1.05 Billion HKD | 20.084% |
| Essex Bio-Technology Limited | 1.7 Billion HKD | 50.688% |
| Tongfang Kontafarma Holdings Limited | 809.1 Million HKD | -4.009% |
| PuraPharm Corporation Limited | 406.85 Million HKD | -106.839% |
| SSY Group Limited | 6.46 Billion HKD | 86.979% |
| JBM (Healthcare) Limited | 648.41 Million HKD | -29.785% |
| Jacobson Pharma Corporation Limited | 1.46 Billion HKD | 42.666% |
| China Resources Pharmaceutical Group Limited | 270.39 Billion HKD | 99.689% |